drugset / Trial / NCT02266589

Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

NCT02266589

Phase 3 Completed 84 enrolled Nanjing PLA General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to find out whether stress doses of hydrocortisone attenuate coagulation dysfunction in patients with septic shock. And discuss the probable mechanism by which little doses of hydrocortisone influence coagulation system in sepsis.

Timeline

Start
2011-11
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 50 mg Intravenous